Noopept stimulates the expression of NGF and BDNF in rat hippocampus.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1007\/s10517-008-0297-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective and nootropic drug noopept rescues \u03b1-synuclein amyloid cytotoxicity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1016\/j.jmb.2011.09.044<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.ejps.2021.105909<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1007\/s10517-008-0211-6<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.32607\/20758251-2016-8-1-82-89<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC4837574?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ostrovskaya RU<\/author><author>Vakhitova YV<\/author><author>Kuzmina USh et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation.<\/title><secondary-title>Journal of biomedical science<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1186\/s12929-014-0074-2<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC4422191?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.3390\/ijms24010690<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1422-0067\/24\/1\/690\/pdf?version=1672968610<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1007\/s10517-016-3344-z<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Noopept in the treatment of mild cognitive impairment in patients with stroke].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Araj SK<\/author><author>Szeleszczuk \u0141<\/author><author>Gubica T et al.<\/author><\/authors><\/contributors><titles><title>Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity.<\/title><secondary-title>Journal of pharmaceutical and biomedical analysis<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1016\/j.jpba.2024.116474<\/electronic-resource-num><urls><related-urls><url>http:\/\/dx.doi.org\/10.1016\/j.jpba.2024.116474<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>\u0411. \u0421. \u0411\u0443\u0440\u043b\u0430\u043a\u0430<\/author><author>\u0418. \u0424. \u0411\u0435\u043b\u0435\u043d\u0438\u0447\u0435\u0432<\/author><author>\u0412. \u0412. \u0413\u043b\u0430\u0434\u044b\u0448\u0435\u0432<\/author><\/authors><\/contributors><titles><title>Thermogravimetric investigation of a new intranasal gel with noopept<\/title><secondary-title>Farmatsevtychnyi zhurnal<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.32352\/10.32352\/0367-3057.6.19.06<\/electronic-resource-num><urls><related-urls><url>https:\/\/pharmj.org.ua\/index.php\/journal\/article\/download\/764\/718<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>\u0411. \u0421. \u0411\u0443\u0440\u043b\u0430\u043a\u0430<\/author><\/authors><\/contributors><titles><title>Thermogravimetric investigation of a new intranasal gel with noopept<\/title><secondary-title>DOAJ (DOAJ: Directory of Open Access Journals)<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.32352\/0367-3057.6.19.06<\/electronic-resource-num><urls><related-urls><url>https:\/\/doaj.org\/article\/60131894f20f42f5894e396f5c51f56a<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.heliyon.2021.e06219<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06219<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[Preclinical study of noopept toxicity].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.18097\/pbmc20186405455<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>G\u00fcrb\u00fcz P<\/author><author>D\u00fczova H<\/author><author>Yildiz A et al.<\/author><\/authors><\/contributors><titles><title>Effects of noopept on cognitive functions and pubertal process in rats with diabetes.<\/title><secondary-title>Life sciences<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/j.lfs.2019.116698<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gurbuz P<\/author><author>Duzova H<\/author><author>Taslidere AC et al.<\/author><\/authors><\/contributors><titles><title>Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.<\/title><secondary-title>Biotechnic & histochemistry : official publication of the Biological Stain Commission<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/10520295.2023.2187460<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zainullina LF<\/author><author>Ivanova TV<\/author><author>Sadovnikov SV et al.<\/author><\/authors><\/contributors><titles><title>Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.<\/title><secondary-title>Doklady. Biochemistry and biophysics<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1134\/S1607672920050129<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ostrovskaia RU<\/author><author>Gudasheva TA<\/author><author>Voronina TA et al.<\/author><\/authors><\/contributors><titles><title>[The original novel nootropic and neuroprotective agent noopept].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>et al.<\/author><\/authors><\/contributors>Noopept stimulates the expression of NGF and BDNF in rat hippocampus.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1007\/s10517-008-0297-x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective and nootropic drug noopept rescues \u03b1-synuclein amyloid cytotoxicity.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1016\/j.jmb.2011.09.044<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>QbD-driven development of dissolving microneedle patch loaded with ultradeformable liposomes encapsulated Noopept: Exploring a patient friendly, once-daily option to manage dementia.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.ejps.2021.105909<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by beta-amyloid25-35 injection into Meynert basal nuclei of rats).<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1007\/s10517-008-0211-6<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.32607\/20758251-2016-8-1-82-89<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC4837574?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ostrovskaya RU<\/author><author>Vakhitova YV<\/author><author>Kuzmina USh et al.<\/author><\/authors><\/contributors><titles><title>Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation.<\/title><secondary-title>Journal of biomedical science<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1186\/s12929-014-0074-2<\/electronic-resource-num><urls><related-urls><url>https:\/\/europepmc.org\/articles\/PMC4422191?pdf=render<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Intranasal Administration of Forskolin and Noopept Reverses Parkinsonian Pathology in PINK1 Knockout Rats.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2022<\/year><\/dates><electronic-resource-num>10.3390\/ijms24010690<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.mdpi.com\/1422-0067\/24\/1\/690\/pdf?version=1672968610<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2016<\/year><\/dates><electronic-resource-num>10.1007\/s10517-016-3344-z<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Noopept in the treatment of mild cognitive impairment in patients with stroke].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[Clinical and electroencephalographic characteristic of noopept in patients with mild cognitive impairment of posttraumatic and vascular origin].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Araj SK<\/author><author>Szeleszczuk \u0141<\/author><author>Gubica T et al.<\/author><\/authors><\/contributors><titles><title>Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept) - An active pharmaceutical ingredient with nootropic activity.<\/title><secondary-title>Journal of pharmaceutical and biomedical analysis<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1016\/j.jpba.2024.116474<\/electronic-resource-num><urls><related-urls><url>http:\/\/dx.doi.org\/10.1016\/j.jpba.2024.116474<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>\u0411. \u0421. \u0411\u0443\u0440\u043b\u0430\u043a\u0430<\/author><author>\u0418. \u0424. \u0411\u0435\u043b\u0435\u043d\u0438\u0447\u0435\u0432<\/author><author>\u0412. \u0412. \u0413\u043b\u0430\u0434\u044b\u0448\u0435\u0432<\/author><\/authors><\/contributors><titles><title>Thermogravimetric investigation of a new intranasal gel with noopept<\/title><secondary-title>Farmatsevtychnyi zhurnal<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.32352\/10.32352\/0367-3057.6.19.06<\/electronic-resource-num><urls><related-urls><url>https:\/\/pharmj.org.ua\/index.php\/journal\/article\/download\/764\/718<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>\u0411. \u0421. \u0411\u0443\u0440\u043b\u0430\u043a\u0430<\/author><\/authors><\/contributors><titles><title>Thermogravimetric investigation of a new intranasal gel with noopept<\/title><secondary-title>DOAJ (DOAJ: Directory of Open Access Journals)<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.32352\/0367-3057.6.19.06<\/electronic-resource-num><urls><related-urls><url>https:\/\/doaj.org\/article\/60131894f20f42f5894e396f5c51f56a<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>Noopept; a nootropic dipeptide, modulates persistent inflammation by effecting spinal microglia dependent Brain Derived Neurotropic Factor (BDNF) and pro-BDNF expression throughout apoptotic process.<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1016\/j.heliyon.2021.e06219<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.1016\/j.heliyon.2021.e06219<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>et al.<\/author><\/authors><\/contributors><titles><title>[Preclinical study of noopept toxicity].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><\/authors><\/contributors><titles><title>[Pharmacokinetics of noopept and its active metabolite cycloprolyl glycine in rats].<\/title><secondary-title><\/secondary-title><\/titles><dates><year>2018<\/year><\/dates><electronic-resource-num>10.18097\/pbmc20186405455<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>G\u00fcrb\u00fcz P<\/author><author>D\u00fczova H<\/author><author>Yildiz A et al.<\/author><\/authors><\/contributors><titles><title>Effects of noopept on cognitive functions and pubertal process in rats with diabetes.<\/title><secondary-title>Life sciences<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.1016\/j.lfs.2019.116698<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gurbuz P<\/author><author>Duzova H<\/author><author>Taslidere AC et al.<\/author><\/authors><\/contributors><titles><title>Effects of noopept on ocular, pancreatic and renal histopathology in streptozotocin induced prepubertal diabetic rats.<\/title><secondary-title>Biotechnic & histochemistry : official publication of the Biological Stain Commission<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1080\/10520295.2023.2187460<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Zainullina LF<\/author><author>Ivanova TV<\/author><author>Sadovnikov SV et al.<\/author><\/authors><\/contributors><titles><title>Cognitive Enhancer Noopept Activates Transcription Factor HIF-1.<\/title><secondary-title>Doklady. Biochemistry and biophysics<\/secondary-title><\/titles><dates><year>2020<\/year><\/dates><electronic-resource-num>10.1134\/S1607672920050129<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Ostrovskaia RU<\/author><author>Gudasheva TA<\/author><author>Voronina TA et al.<\/author><\/authors><\/contributors><titles><title>[The original novel nootropic and neuroprotective agent noopept].<\/title><secondary-title>Eksperimental'naia i klinicheskaia farmakologiia<\/secondary-title><\/titles><dates><year>2002<\/year><\/dates><\/record>\n<\/records><\/xml>\n"